$0.152
-0.005[-3.18%]
At close: Apr 19
$0.152
0[0.00%]
After Hours: 7:58PM EDT
Tonix Pharmaceuticals
(NASDAQ:TNXP)Latest News for Tonix Pharmaceuticals Stock (NASDAQ:TNXP)
Tonix Pharmaceuticals Stock (NASDAQ: TNXP)
Categories: All
Monday, April 01, 2024
Friday, March 29, 2024
Thursday, March 28, 2024
- Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Mar 28, 2024, 2:08PM
- Why Tonix Pharmaceuticals Stock (TNXP) Is Getting ObliteratedHenry Khederian - Mar 28, 2024, 1:02PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Mar 28, 2024, 12:31PM
- Tonix Pharmaceuticals Holding shares are trading lower after the company announced the pricing of a $4.4 million registered direct offering.Benzinga Newsdesk - Mar 28, 2024, 11:21AM
- Tonix Pharmaceuticals Prices $4.4M Registered Direct Offering Of 14,666,666 Shares And Warrants At $0.30/Share; Warrants Have Exercise Price Of $0.33/ShareBenzinga Newsdesk - Mar 28, 2024, 9:35AM
Monday, March 25, 2024
Thursday, March 21, 2024
Tuesday, March 19, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
Wednesday, February 14, 2024
Tuesday, February 13, 2024
Friday, February 09, 2024
Thursday, February 01, 2024
Wednesday, January 31, 2024
- Tonix Pharmaceuticals Research Indicates Pre-Existing Fibromyalgia-Type Symptoms May Increase The Risk Of Developing Long COVIDBenzinga Newsdesk - Jan 31, 2024, 7:10AM
- Tonix Pharmaceuticals Announces Research Indicating Pre-existing Fibromyalgia-type Symptoms May Increase The Risk Of Developing Long COVIDBenzinga Newsdesk - Jan 31, 2024, 7:08AM
Tuesday, January 30, 2024
Monday, January 29, 2024
Wednesday, January 03, 2024
Wednesday, December 20, 2023
- Why Tonix Pharmaceuticals (TNXP) Shares Are PlummetingHenry Khederian - Dec 20, 2023, 12:52PM
- Tonix Pharmaceuticals shares are trading lower after the company announced a registered direct offering of up to $144 million. Also, the company announced topline results for its Phase 3 RESILIENT study evaluating TNX-102 SL for the management of fibromyalgia, which could also be impacting the stock.Benzinga Newsdesk - Dec 20, 2023, 12:43PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Dec 20, 2023, 12:31PM
- Tonix Pharmaceuticals Announces Registered Direct Offering Of Up To $144M; $30M Financing Upfront With Up To An Additional $114M Tied To The Exercise Of WarrantsBenzinga Newsdesk - Dec 20, 2023, 10:36AM
- Tonix Pharmaceuticals Announces Statistically Significant And Clinically Meaningful Topline Results In Second Phase 3 Clinical Trial Of TNX-102 SL For The Management Of FibromyalgiaBenzinga Newsdesk - Dec 20, 2023, 10:31AM
Thursday, December 14, 2023
Monday, December 11, 2023
Friday, December 08, 2023
Thursday, December 07, 2023
Friday, November 17, 2023
Wednesday, November 15, 2023
Thursday, November 09, 2023
Thursday, November 02, 2023
Wednesday, November 01, 2023
- Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 1, 2023, 1:59PM
- Tonix Pharmaceuticals shares are trading lower after the company announced topline results from the Phase 2 proof-of-concept study of TNX-601 ER for the treatment of major depressive disorder did not achieve clinical or statistical significance.Benzinga Newsdesk - Nov 1, 2023, 11:16AM
- Why Tonix Pharmaceuticals (TNXP) Stock Is Falling Sharply TodayHenry Khederian - Nov 1, 2023, 10:58AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Nov 1, 2023, 9:06AM